Prostate Cancer - Results from #27580

Circulating tumor cells in prostate cancer: A potential surrogate marker of survival - Abstract July 6, 2011

Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients - Abstract July 6, 2011

Targeting continued androgen receptor signaling in prostate cancer - Abstract July 6, 2011

Immunotherapy for prostate cancer: Recent advances, lessons learned, and areas for further research - Abstract July 6, 2011

Testicular biopsy for early cancer detection - objectives, technique and controversies - Abstract July 6, 2011

Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer - Abstract July 5, 2011

The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention - Abstract July 5, 2011

Omega-3 fatty acid inhibition of prostate cancer progression to hormone independence is associated with suppression of mTOR signaling and androgen receptor expression - Abstract July 5, 2011

Novel method of knotless vesicourethral anastomosis during robot-assisted radical prostatectomy: Feasibility study and early outcomes in 30 patients using the interlocked barbed unidirectional V-LOC180 suture - Abstract July 5, 2011

Brief report - A bioassay to identify primary human prostate cancer repopulating cells - Abstract July 5, 2011

Evolution from active surveillance to focal therapy in the management of prostate cancer - Abstract July 5, 2011

Recent advances in immunotherapy for the treatment of prostate cancer - Abstract July 5, 2011

Biochemical outcome of small-volume or insignificant prostate cancer treated with radical prostatectomy in Japanese population - Abstract July 5, 2011

Clinical outcomes of prostate cancer patients detected by prostate-specific antigen-based population screening in Kanazawa City, Japan - Abstract July 5, 2011

BMP4 promotes prostate tumor growth in bone through osteogenesis - Abstract July 4, 2011

Radiation therapy for prostate cancer after prostatectomy: Adjuvant or salvage? - Abstract July 4, 2011

Experience in the use of sunitinib given as a single agent in metastatic chemoresistant and castration-resistant prostate cancer patients - Abstract July 4, 2011

Normal prostate-derived stromal cells stimulate prostate cancer development - Abstract July 4, 2011

Surgical margin status among men with organ-confined (pT2) prostate cancer: A population-based study - Abstract July 4, 2011

Randomized study evaluating testosterone recovery using short-versus long-acting luteinizing hormone releasing hormone agonists - Abstract July 4, 2011

Page 1380 of 1437